Axsome Therapeutics: Q2 Earnings Insights

 

Axsome Therapeutics AXSM reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Axsome Therapeutics beat estimated earnings by 14.52%, reporting an EPS of $-1.06 versus an estimate of $-1.24.

Revenue was up $8.82 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 5.29% increase in the share price the next day.

 

To track all earnings releases for Axsome Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

AXSM Logo
AXSMAxsome Therapeutics Inc
$103.360.77%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
81.87
Growth
Not Available
Quality
Not Available
Value
15.98
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...